Generex Biotechnology Corp. (fka GNBTQ)

[houvp]

I had also noticed the Hema article, but it is just a non-binding LOI and I don't see that GNBT has money to carry through with it. Of course, there have been no SEC filings or news of late. That said, there was some news recently about rapid diagnostic tests. Biocan Diagnostics released a rapid Zika test in March 2016 that is available for order ( www.rapidtest.ca and www.zikatest.com) interesting that they are also located in Canada, like GNBT, though one in BC, the other in ON. Harvard has just released news of progress with a rapid paper tests (changes color with positive indication) that has had some good initial test results, but not on the market yet. It seems as likely, if not more so, to me that the recent bump in GNBT is coming from The Parker Foundation's huge new $250 million initiative to wipe out cancer using immunotherapy. They have pulled together "the best and the brightest" from several key universities and are determined to achieve this goal at any cost. Whether GNBT spins off AE, or they are acquired, or how this might unfold is beyond my ability to predict, but it seems GNBT/AE is uniquely positioned in immunotherapy to possibly play a role in this new initiative. http://parker.org